Barbara Ann Karmanos Cancer Institute
The Barbara Ann Karmanos Cancer Institute will hold its 20th Annual Partners Events this fall in support of its nationally recognized comprehensive cancer research programs. Proceeds from the events will fund important scientific recruitment initiatives, bringing promising talent to Detroit and further strengthening Karmanos’ accomplished research programs. The honorees for this year’s Partners Events are Danialle and Peter Karmanos, Jr.
The latest event and meeting notices from Michigan’s technology-focused people, groups, institutions and companies
The Detroit Tigers and the Barbara Ann Karmanos Cancer Institute are teaming up for the second annual Pink Out the Park at the Detroit Tigers vs. Kansas City Royals game Friday, Sept. 13, at 7:08 p.m., at Comerica Park.
The Barbara Ann Karmanos Cancer Institute’s Annual Dinner, April 20, has already raised more than $2.2 million toward its $2.5 million goal, thanks in part to the auction of the first regular retail production 2014 Chevrolet Corvette Stingray Convertible, donated by Chevrolet.
The Barbara Ann Karmanos Cancer Institute has announced the successful completion of the $3 million Herrick Cancer Research Challenge, with an approximately $5.7 million total impact, exceeding challenge goals.
The General Motors Foundation donated $400,000 for the second straight year to support cancer research at the Barbara Ann Karmanos Cancer Institute.
SoftVue, the whole breast ultrasound imaging device created by two scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, is currently undergoing review by the U.S. Food and Drug Administration for market clearance.
The Barbara Ann Karmanos Cancer Institute’s 30th Annual Dinner held Saturday, April 28, raised nearly $1.7 million to benefit Karmanos’ exceptional cancer care, making this the most successful Annual Dinner in Karmanos’ history.
The latest awards, prizes and professional certifications earned by Michigan’s technology-focused institutions and people
Scientists at the Barbara Ann Karmanos Cancer Institute in Detroit today presented data at the American Association for Cancer Research’s 102nd Annual Meeting 2011 showing that when tumor cryoablation — or the freezing of tumor tissue while preserving tumor-associated antigens — is coupled with immune system modulation, the procedures have the potential to initiate or amplify tumor immunity.